|
|||
|
|||||
Financial Statements 2001 NOTES to the FINANCIAL statements |
Go
to Notes: 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 |
3 WORKERS' COMPENSATION At the end of fiscal year 2001, we estimate our total liability for future workers' compensation costs, excluding Post Office Department (POD) liability, at $5,804 million. At the end of 2000, this liability was $5,560 million. In 2001, we recorded $970 million in workers' compensation expense, compared to the $911 million we recorded in 2000 and the $603 million we recorded in 1999. Our liability for future workers' compensation costs for POD claims was $172 in 2001 and $193 million in 2000. In 2001, we recorded an expense of $9 million for POD, compared to the $14 million we recorded in 2000 and the $11 million we recorded in 1999. In fiscal year 2000, we refined our methodology used to estimate the present value of the total amounts we expect to pay for current Postal Service workers' compensation claims. The major refinement is the use of a life table that reflects long-term experience with a disabled population to estimate mortality rates of our permanently disabled population. Previously, we had used a life table that reflected experience with the general United States population. In management's opinion, the refinements result in a better estimation of our liability for future outlays on behalf of Postal Service workers' compensation claimants. The effect of the refinements was a reduction of $423 million in the fiscal year 2000 compensation and benefits expense. In fiscal year 1999, we adopted a change in the net discount rate used in determining the present value of estimated future workers' compensation payments for medical claims. The net discount rate for medical claims was changed from 0.1% to 1.4%. The effect of the adoption of this rate has been accounted for as a change in accounting estimate. It resulted in a decrease of $131 million in the fiscal year 1999 compensation and benefits expense. In management's opinion, this net discount rate better reflects the excess of rates of return on government debt instruments of comparable terms relative to expected future medical inflation. |
continue... |